ACS and stroke 2 Flashcards

1
Q

Why are anti-platelet drugs used?

A

The major role played by platelets in clot formation makes them a logical target for drugs that aim to reduce the risk of thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aspirin

A

most commonly used drug for secondary prevention

irreversible inhibitor of cyclooxygenase (enzyme)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which type of thrombosis is it most important for?

A

arterial thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Generation of TXA2

A

synthetic pathway for TXA2 begins with phospholipase A2 cleaving membrane phospholipids and releasing the fatty acid arachidonic acid into the cytoplasm

series of enzymatic steps then occurs that result in the formation of prostaglandin H2

one of these steps is catalysed by cyclooxygenase

thromboxane synthase then acts on prostaglandin H2 to produce TXA2.

if cyclooxygenase is blocked using aspirin production of TXA2 is blocked

prostaglandin H2 is actually a branch point

prostacyclin synthase (enzyme) can act on prostaglandin H2 to produce prostacyclin which is a signal that stops a chain reaction of platelet activation spreading through the circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aspirin dose

A

Aspirin is given at a low dose once a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is thromboxane A2 made?

A

platelets (no nuclei)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is Prostacyclin made?

A

endothelial cells (no nuceli)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens initially?

A

all COX inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can endothelial cells can overcome inhibition?

A

because they have a nucleus they can make more prostacyclin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do platelets do because they cannot make new enzymes?

A

need new platelets to make COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COX-2

A

endothelial cells have a second type of COX (COX-2) that is not as sensitive to aspirin which contributes to ability to continue prostacyclin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aspirin as a painkiller

A

Aspirin was initially marketed as a painkiller and anti-inflammatory drug but it has been largely been superseded in these roles by safer drugs such as ibuprofen and paracetamol

Its mechanism as a painkiller and anti-inflammatory overlaps with its antiplatelet actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which class of drugs do aspirin and ibuprofen belong to?

A

non-steroidal anti-inflammatory drugs (NSAIDs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is cyclooxygenase important for?

A

produces prostaglandins that act as pain signals and inflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side effects of aspirin (4)

A
  • extended bleeding
  • irritating to stomach and GI tract- ulcers, bleeding, removes protective prostaglandins
  • Reye’s syndrome (under 16)
  • Can provoke asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADP receptor inhibitors

A

ADP released from activated platelets and acts on a G protein coupled receptor called P2Y12 on neighbouring inactive platelets

these receptors promote activation of the platelets and increase the number of the GPIIb/IIIa glycoprotein receptors on their surface (the receptors that allow cross linking of platelets via fibrinogen)

13
Q

What do drugs that block effects of ADP end with?

14
Q

Clopidogrel and prasugrel

A

Clopidogrel and prasugrel (prodrugs) are irreversible inhibitors of the P2Y12 receptor and so block the actions of ADP by essentially “killing” the receptor

15
Q

How are clopidogrel and prasugrel activated?

A

clopidogrel must be metabolized by the enzyme CYP2C19

15
Q

Issue with clopidogrel

A

about 30% of people have a genetic difference in this enzyme that means they cannot metabolize clopidogrel effectively

because of this issue NICE recommended that genetic testing be introduced to identify patients for whom clopidogrel would be ineffective

16
Q

Why is there not the same issue with prasugrel

A

prasugrel is also a prodrug but is much less dependent on CYP2C19 for its metabolism to the active form and will work more consistently across all patients.

17
Q

Ticagrelor

A

inhibitor of the P2Y12 receptor but binds to a different site to ADP (it is an allosteric or non-competitive antagonist)

unlike clopidogrel and prasugrel it is not a prodrug and it binds to the receptor reversibly

18
Q

Side effects of ALL ADP receptor inhibitors

A

extended bleeding in a dose dependent manner

19
Q

Side effects of clopidogrel

A

Common: gastrointestinal tract problems

Less common: dizziness, headache

20
Side effects of prasugrel
Common: anaemia, skin reactions Less common: angioedema
21
Side effects of ticagrelor
Common: gastrointestinal tract problems, dizziness, headache, gout, skin reactions Less common: confusion, angioedema
22
When are antiplatelet drugs used?
- aspirin no longer given for routine primary prevention - anti platelet drugs used mostly for secondary prevention
22
When are antiplatelet drugs used in stable angina?
aspirin or clopidogrel if aspirin not tolerated
23
When are antiplatelet drugs used in ACS?
aspirin in combination with either ticagrelor, prasugrel or clopidogrel for up to 12 months known as dual antiplatelet therapy (DAPT)- after that, aspirin alone will be continued indefinitely (or clopidogrel if aspirin is not tolerated)
24
When are antiplatelet drugs used in transient ischaemic attack or stroke?
Once it is certain that the patient has suffered an ischaemic event, rather than a haemorrhagic stroke patient is given aspirin during the first 48 hours longer term the patient will be given clopidogrel, or if clopidogrel is unsuitable for them, low dose aspirin can be used instead
25
Drugs acting via antithrombin III
drugs in this class exploit one of the regulatory points in the coagulation pathway. there is an endogenous regulator of the cascade called antithrombin III (ATIII), which inhibits the actions of both thrombin and factor Xa drugs that bind to ATIII and increase its affinity for these coagulation factors will therefore block the production of fibrin
26
Pharmacokinetics of amiodarone
27
28
29
30
30